TCRX earnings: a positive outcome, +42.6%

On May 10, 2023, TScan Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +42.6% in the window around the event. It had already run +10.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.